City

Toronto (1)

Condition

Peritoneal Dialysis Complication (2)

Residual Kidney Function (2)

End Stage Kidney Disease (1)

Health-related Quality of Life (1)

Kidney Dysfunction (1)

Sodium-glucose Co-transporter-2 Inhibitors (1)

Survival (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

RenJi Hospital (1)

University Health Network, Toronto (1)

Collaborator

Intervention

conventional pd group (1)

empagliflozin 25 mg (1)

single daily icodextrin exchange (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

residual kidney function

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Peritoneal Dialysis Complication, Residual Kidney Function, Survival Trial (Single daily icodextrin exchange, Conventional PD

Not yet recruiting

Peritoneal Dialysis Complication
+3 more

Single daily icodextrin exchange
Conventional PD group

(no location specified)

Nov 5, 2023

Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Trial in Toronto

Not yet recruiting

Peritoneal Dialysis Complication
+4 more

Empagliflozin 25 MG

Toronto, Ontario, Canada

Toronto General Hospital

Jan 27, 2023